@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAJ3WfoRPSv5o3zddf7By0zfuHMwKSGN2wnW0-r-obyso> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAJ3WfoRPSv5o3zddf7By0zfuHMwKSGN2wnW0-r-obyso#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix chebi: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=> .
@prefix sdis: <http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-diseases/> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   sub:_1 occursIn: obo:CL_0000169 , obo:UBERON_0002385 , species:9606 ;
    rdf:object sdis:muscle%20glucose%20import ;
    rdf:predicate belv:increases ;
    rdf:subject chebi:6801 ;
    a rdf:Statement .
  sub:assertion rdfs:label "a(CHEBI:metformin) -> path(SDIS:\"muscle glucose import\")" .
}
sub:provenance {
   beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_3 ;
    pav:version "20131211" .
  sub:_2 prov:value "Metformin also enhances muscle insulin sensitivity through direct (97, 98) and indirect effects (99). At the cellular level, improved insulin action in muscle is explained by multiple actions, including increased insulin receptor tyrosine kinase activity (100), augmented GLUT4 transporter number and activity (101), and enhanced glycogen synthesis" ;
    prov:wasQuotedFrom pubmed:10454950 .
  sub:_3 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:10454950 ;
    prov:wasDerivedFrom beldoc: , sub:_2 .
}
sub:pubinfo {
   this: dct:created "2014-07-03T14:31:31.647+02:00"^^xsd:dateTime ;
    pav:createdBy orcid:0000-0001-6818-334X , orcid:0000-0002-1267-0234 .
}